BMY Related Analyst PT Change
-
Goldman Sees Blockbuster Potential for Bristol-Myers Squibb's (BMY) Nivolumab (PD-1)
-
Bristol-Myers Squibb Company (BMY) Moves Higher Ahead of ASCO Presscast / Abstracts
-
Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)
-
BMO Capital Downgrades Bristol-Myers Squibb Co. (BMY) to Market Perform
-
Goldman Sachs Upgrades Bristol-Myers Squibb Co. (BMY) to Conviction Buy
-
UBS Reiterates a 'Buy' on Gilead Sciences (GILD); Raises Numbers on Favorite Large-Cap Biotech
-
Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)
-
Buy Bristol-Myers (BMY) On Weakness - Jefferies
-
UBS on Bristol-Myers Squibb's (BMY) INX-189 Stumble: At Best Puts Bristol Behind; At Worst, Out of the Race
-
Jefferies on Pharmaceuticals: Global Pharmaceuticals Q2'12 Earnings Preview; Where is it Safe to Hide?
Back to BMY Stock Lookup
